retatrutide triple agonist weight loss trial 🚨 TRIUMPH-1 Phase 3 top-line results, much awaited and just announced ⬇️ 28.3% at 80 weeks ⬇️ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 retatrutide #obesity #osteoarthritis #clinicaltrials #medicine

Trava Health may be ideal for budget-conscious patients, but it has ongoing issues with fulfillment and support

If that fits your goals and background, the platform is worth evaluating through the intake process

For patients who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone, GLP-1 therapy offers a potent alternative with greater potency and longer half-life compared to some other GLP-1 RA therapies

However, long-term risks such as rare adverse effects, metabolic effects over years, effects on bone, gallbladder, and pancreas need phase-3 trials and post-marketing surveillance to ensure the medication is safe for long-term use

A.KatsikiN.BlundellJ.FruhbeckG.KiortsisD

MEDVi starts at $179 for the first month of compounded semaglutide but increases to $299 for subsequent months